On the other hand, IL-17a showed increased levels in IL-17F over-expression HCT116 cells and decreased levels in the colon tissues of AOM-DSS treated il-17f−/− mice, suggesting a compensatory regulation of IL-17F and IL-17A gene expressions in colon cancer. Here, IL17F is linked to malignant colon neoplasm.